2016
DOI: 10.1159/000442773
|View full text |Cite
|
Sign up to set email alerts
|

ZEISS Angioplex™ Spectral Domain Optical Coherence Tomography Angiography: Technical Aspects

Abstract: ZEISS Angioplex™ optical coherence tomography (OCT) angiography generates high-resolution three-dimensional maps of the retinal and choroidal microvasculature while retaining all of the capabilities of the existing CIRRUS™ HD-OCT Model 5000 instrument. Angioplex™ OCT angiographic imaging on the CIRRUS™ HD-OCT platform was made possible by increasing the scanning rate to 68,000 A-scans per second and introducing improved tracking software known as FastTrac™ retinal-tracking technology. The generation of en face… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
176
0
7

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 218 publications
(191 citation statements)
references
References 3 publications
1
176
0
7
Order By: Relevance
“…The Angioplex uses optical microangiography, a recently developed imaging technique that produces 3D images of the dynamic blood flow within the microcirculatory tissue beds. 11,14 A scanned area of 3 3 3 mm centered on the fovea was used. All acquisitions were performed using the FastTrac retinal-tracking technology (Carl Zeiss Meditec, Inc.) to reduce motion artifacts.…”
Section: 13mentioning
confidence: 99%
See 1 more Smart Citation
“…The Angioplex uses optical microangiography, a recently developed imaging technique that produces 3D images of the dynamic blood flow within the microcirculatory tissue beds. 11,14 A scanned area of 3 3 3 mm centered on the fovea was used. All acquisitions were performed using the FastTrac retinal-tracking technology (Carl Zeiss Meditec, Inc.) to reduce motion artifacts.…”
Section: 13mentioning
confidence: 99%
“…To accomplish this, we used the Cirrus 5000 with Angioplex OCTA to obtain en face images of the superficial plexus, deep plexus, and the whole retina of 53 eyes of RP patients. 11 The OCTA images were analyzed with the Angio Exerciser software (Carl Zeiss Meditec, Inc., Dublin, CA, USA), which quantified the microvascular changes of not only the vascular density but also the indices of vascular thickness and length. In addition, we examined whether the correlations between the microvascular indices and the retinal function and structure, including the best-corrected visual acuity (BCVA), automated static perimetry findings, and OCT findings, were significant.…”
mentioning
confidence: 99%
“…1 OCT-A relies on the principle that erythrocytes flowing in blood vessels are the only moving structure across co-registered sequential B-scans and, therefore, they can be used as a motion contrast to differentiate vessels from static tissues. 1 Based on this assumption, several algorithms have been developed by many instruments including complex optical microangiography (OMAG) for Zeiss devices (Angioplex and PLEX Elite 9000; Carl Zeiss Meditec, Inc., Dublin, CA, USA), 2,3 split spectrum amplitude decorrelation angiography algorithm (SSADA) for RTVue XR Avanti (Optovue Inc., Fremont, CA, USA), 4 OCT angiography ratio analyses (OCTARA) for DRI OCT Triton (Topcon, Tokyo, Japan), 5 and full-spectrum amplitude decorrelation algorithm (FSADA) for Heidelberg (Spectralis; HRA Heidelberg, Heidelberg, Germany). 6 All these machines provide en face angiogram images, which can be postprocessed in order to obtain quantitative parameters, such as foveal avascular zone (FAZ) area and vessel density.…”
mentioning
confidence: 99%
“…8,9 OCTA therefore enables detailed and reproducible images of the retinal microvasculature networks to be obtained with a high level of resolution. 10 The foveal avascular zone (FAZ) is the round, capillary-free zone within the macula. Measurements of FAZ size (area and perimeter) using OCTA have been shown to be highly reproducible in patients with microcirculatory deficiency involving the macula, such as diabetic retinopathy, as well as in healthy individuals.…”
mentioning
confidence: 99%